Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArTara Therapeutics, Inc.

3.45
-0.0500-1.43%
Volume:330.66K
Turnover:1.15M
Market Cap:126.85M
PE:-1.59
High:3.60
Open:3.53
Low:3.41
Close:3.50
Loading ...

Protara Therapeutics Q4 Net Income USD -12.769 Million

THOMSON REUTERS
·
05 Mar

Protara Therapeutics Q4 Operating Expenses USD 14.312 Million

THOMSON REUTERS
·
05 Mar

BRIEF-Protara Therapeutics Completed Approximately $100 Million Public Offering, Extending Runway Into 2027

Reuters
·
13 Jan

Protara Therapeutics Inc: Completed Approximately $100 Mln Public Offering, Extending Runway Into 2027

THOMSON REUTERS
·
13 Jan

Protara Therapeutics Closes $100 Million Securities Offering

MT Newswires Live
·
12 Dec 2024

Protara Therapeutics Prices $100 Million Offering of Shares, Pre-Funded Warrants

MT Newswires Live
·
10 Dec 2024

BRIEF-Protara Prices Public Offering Of 13.69 Mln Shares At $6.25 Per Share

Reuters
·
10 Dec 2024

Protara Announces Pricing of $100 Million Public Offering

THOMSON REUTERS
·
10 Dec 2024

Protara Therapeutics Inc - Prices Public Offering of 13.69 Mln Shares at $6.25 per Share

THOMSON REUTERS
·
10 Dec 2024

Protara Therapeutics Launches Common Stock Offering; Shares Fall After Hours

MT Newswires Live
·
10 Dec 2024

BUZZ-Protara Therapeutics slides after unveiling stock deal

Reuters
·
10 Dec 2024

Protara Therapeutics Shares Down 8.2% After the Bell; Announces Proposed Public Offering

THOMSON REUTERS
·
10 Dec 2024

Protara Therapeutics announces common stock offering, no amount given

TIPRANKS
·
10 Dec 2024

BRIEF-Protara Announces Proposed Public Offering

Reuters
·
10 Dec 2024

Protara Announces Proposed Public Offering

THOMSON REUTERS
·
10 Dec 2024

Protara Therapeutics Inc - to Use Proceeds to Fund Clinical Development of Tara-002

THOMSON REUTERS
·
10 Dec 2024

Press Release: Protara Announces Proposed Public Offering

Dow Jones
·
10 Dec 2024

TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy

Zacks
·
06 Dec 2024

Protara Therapeutics Price Target Maintained With a $23.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Dec 2024

Promising Efficacy of TARA-002 Positions Protara Therapeutics as a Compelling Buy for HR-NMIBC Treatment

TIPRANKS
·
06 Dec 2024